Skip to main content

Pelvic Inflammatory Disease, Pediatric

Maria Trent, MD, MPH Reviewed 10/2018
 


BASICS

DESCRIPTION

  • Pelvic inflammatory disease (PID) refers to a spectrum of upper female genital tract inflammatory disorders, including endometritis, salpingitis, tubo-ovarian abscess (TOA), and peri...

DIAGNOSIS

ALERT
  • Clinical criteria for PID are designed to have high sensitivity because consequences of untreated PID are significant.

  • If PID suspected based on clinical presentation and examination, tr...

TREATMENT

ALERT
  • All CDC-recommended regimens for PID require 14-day treatment duration.

  • Fluoroquinolones not recommended for PID treatment because of N. gonorrhoeae resistance

  • Metronidazole treatment sho...

ONGOING CARE

FOLLOW-UP RECOMMENDATIONS

  • All patients diagnosed with PID should have follow-up within 72 hours to assess the following:

    • Treatment tolerance/adherence

    • Symptom improvement

  • If patients are not ...

ADDITIONAL READING

  • Butz AM, Gaydos C, Chung SE, et al. Care-seeking behavior after notification among young women with recurrent sexually transmitted infections after pelvic inflammatory disease. Clin...

CODES

ICD9

  • 614.9 Unspecified inflammatory disease of female pelvic organs and tissues

  • 615.9 Unspecified inflammatory disease of uterus

  • 614.2 Salpingitis and oophoritis not specified as acute, subacute, o...

FAQ

  • Q: My patient has negative testing for N. gonorrhoeae and C. trachomatis, should I have her discontinue the medications if she has clinically improved?

  • A: No. PID is a polymicrobial infection and t...

Subscribe to Access Full Content

Sign Up for a 10-Day Free Trial

Sign up for a 10-day FREE Trial now and receive full access to all content.

 
×